In the wake of the insider-trading probe involving Human Genome Sciences, should journals expand disclosure rules for researchers to include ties to the financial community? Due diligence or transparency overkill?
Plan addresses submission decline
February 15, 2011
7:25 pm
FDA says it is banking on its regulatory science initiative to reverse a decline in new drug and biologic submissions and approvals seen over the past few years.
Agency ‘declassifies’ its secret promotion policy
February 15, 2011
7:24 pm
Twenty months after telling eye care professionals they should report questionable LASIK vision enhancement ads to the agency, FDA in January disclosed a policy of “generally” deferring to the Federal Trade Commission enforcement actions against false or misleading ads and promotions for “restricted” (certain prescription) medical devices.
DIA adds new editor in chief
February 15, 2011
6:59 pm
The Drug Information Association tapped Quintiles’ J. Rick Turner as editor-in-chief of Drug Information Journal, the group’s flagship journal for members.
Elsevier purchases oncology portfolio
February 15, 2011
6:40 pm
Elsevier purchased Cancer Information Group’s (CIG) oncology journal portfolio for an undisclosed sum.
The Alliance for CME (ACME) said it is repositioning itself to be an “all-inclusive education platform” geared toward serving those who educate all healthcare professionals.
An American Journal of Public Health study revealed that only one out of four health-related advocacy groups acknowledges industry funding on its website.
The American Board of Medical Specialties’ white paper examining how CME can support its Maintenance of Certification (MOC) requirement raised hackles among some who foresaw new credit systems, among other harsh consequences.